MarketCap
Facebook
X
Telegram
Titan Pharmaceuticals Kurzfristige Verbindlichkeiten | TTNP
Kurzfristige Verbindlichkeiten Jährlich Titan Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 483 K | 1.44 M | 2.63 M | 2.67 M | 4.22 M | 3.6 M | 3.45 M | 4.46 M | 4.86 M | 4.85 M | 6.66 M | 10.8 M | 21.4 M | 5.12 M | 5.4 M | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.4 M | 483 K | 5.47 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Certara
CERT
|
153 M | $ 12.12 | -0.53 % | $ 1.94 B |  USA |
 |
Dyadic International
DYAI
|
3.69 M | $ 0.33 | -2.68 % | $ 11.9 M | USA |
 |
Intec Pharma Ltd
NTEC
|
5.33 M | - | -12.45 % | $ 17.7 M |  Israel |
 |
Oramed Pharmaceuticals
ORMP
|
19.1 M | $ 3.86 | -0.77 % | $ 160 M | Israel |
 |
Anika Therapeutics
ANIK
|
21.9 M | $ 14.56 | -24.68 % | $ 209 M | USA |
 |
Aprea Therapeutics
APRE
|
2.76 M | $ 0.53 | 6.6 % | $ 3.47 M | USA |
 |
Galectin Therapeutics
GALT
|
8.03 M | $ 3.13 | 4.86 % | $ 200 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
166 M | $ 72.79 | 1.62 % | $ 7.56 B | USA |
 |
Progenity, Inc.
PROG
|
72.7 M | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
2.17 M | $ 2.09 | -0.48 % | $ 1.95 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
21.1 M | - | 1.52 % | $ 136 M | USA |
 |
Seneca Biopharma, Inc.
SNCA
|
3.21 M | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
759 M | $ 56.03 | -0.16 % | $ 10.7 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
1.46 M | $ 1.15 | -0.86 % | $ 6.3 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
48.6 M | $ 10.99 | 9.03 % | $ 234 K | USA |
 |
Milestone Pharmaceuticals
MIST
|
14 M | $ 0.76 | 9.73 % | $ 80.7 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
139 M | $ 93.79 | 6.17 % | $ 6.96 B | USA |
 |
Lipocine
LPCN
|
2.53 M | $ 1.58 | 3.27 % | $ 8.61 M | USA |
 |
Seres Therapeutics
MCRB
|
19.3 M | $ 1.97 | -5.74 % | $ 17.5 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
310 M | $ 399.41 | -0.17 % | $ 8.96 B | USA |
 |
CEL-SCI Corporation
CVM
|
5.13 M | $ 1.44 | 6.67 % | $ 11.5 M | USA |
 |
MeiraGTx Holdings plc
MGTX
|
123 M | $ 9.0 | 5.73 % | $ 724 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
2.24 M | $ 1.93 | 4.89 % | $ 2.53 M | USA |
 |
Eton Pharmaceuticals
ETON
|
38.5 M | $ 56.44 | 19.7 % | $ 1.52 B | USA |
 |
IDEAYA Biosciences
IDYA
|
58.8 M | $ 31.24 | 1.92 % | $ 2.76 B | USA |
 |
Lantern Pharma
LTRN
|
4.5 M | $ 0.56 | 4.61 % | $ 6.1 M | USA |
 |
Foghorn Therapeutics
FHTX
|
59.7 M | $ 1.86 | -2.62 % | $ 117 M | USA |
 |
Ocugen
OCGN
|
23 M | $ 0.93 | 13.53 % | $ 291 M | USA |
 |
Minerva Neurosciences
NERV
|
2.29 M | $ 2.42 | 5.0 % | $ 20.5 M | USA |
 |
Neurocrine Biosciences
NBIX
|
743 M | $ 164.42 | 2.91 % | $ 16.4 B | USA |
 |
Maravai LifeSciences Holdings
MRVI
|
44.9 M | $ 7.53 | 7.81 % | $ 1.09 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
20.9 M | $ 1.78 | 10.25 % | $ 646 M | USA |
 |
Moleculin Biotech
MBRX
|
6.85 M | $ 8.87 | 1.6 % | $ 10.5 M | USA |
 |
Nurix Therapeutics
NRIX
|
86.5 M | $ 15.3 | 3.1 % | $ 1.33 B | USA |
 |
Nkarta
NKTX
|
22.3 M | $ 1.75 | 11.15 % | $ 129 M | USA |
 |
MacroGenics
MGNX
|
43.1 M | $ 2.35 | 5.86 % | $ 148 M | USA |
 |
Protagonist Therapeutics
PTGX
|
45.4 M | $ 131.96 | -2.54 % | $ 8.39 B | USA |
|
Nuvation Bio
NUVB
|
82.2 M | $ 4.15 | -0.72 % | $ 1.42 B | USA |
 |
Marker Therapeutics
MRKR
|
2.27 M | $ 0.91 | 0.95 % | $ 13.9 M | USA |
 |
NextCure
NXTC
|
10.6 M | $ 5.55 | 8.61 % | $ 15.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
11.4 M | $ 1.25 | -1.57 % | $ 65.7 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
51.8 M | $ 7.32 | 8.21 % | $ 637 M | USA |
 |
Kymera Therapeutics
KYMR
|
83.2 M | $ 132.5 | 3.42 % | $ 11.2 B | USA |